💥 Gate廣場活動: #FST创作大赛# 💥
在 Gate廣場 發布 CandyDrop 第71期:CandyDrop x FreeStyle Classic Token (FST) 相關原創內容,即有機會瓜分 3,000 FST 獎勵!
📅 活動時間:2025年8月27日 – 9月2日
📌 參與方式:
發布原創內容,主題需與 FST 或 CandyDrop 活動相關
內容不少於 80 字
帖子添加話題: #FST创作大赛#
附上 CandyDrop 參與截圖
🏆 獎勵設置:
一等獎(1名):1,000 FST
二等獎(3名):500 FST/人
三等獎(5名):200 FST/人
📄 注意事項:
內容必須原創,禁止抄襲或刷量
獲獎者需完成 Gate 廣場身分認證
活動最終解釋權歸 Gate 所有
活動詳情連結: https://www.gate.com/announcements/article/46757
staked INJ ETF proposal
Key Points:* The U.S. SEC evaluates Canary Capital’s proposed Staked INJ ETF.
Canary Capital’s Staked INJ ETF: A Regulatory Milestone
Canary Capital, led by Steven McClurg, submitted a proposal for a Staked INJ ETF via Cboe’s platform, aiming to integrate Injective Protocol and staking rewards within an ETF structure. While this represents a milestone, official statements from Injective Labs are pending.
If approved, the ETF would offer investors access to Injective Protocol without technical hurdles, potentially boosting its ecosystem. This innovation follows the SEC’s recent clarifications on staking activities.
Market analysts anticipate heightened interest, although institutional sentiment varies. Investors and developers are closely monitoring the SEC’s position, which may shape future regulatory frameworks for crypto ETFs.
Injective Protocol: Expert Views and Market Data
Did you know? Canary Capital’s application is part of broader efforts to offer a diversified range of ETFs, including those involving major Layer-1 networks.
According to CoinMarketCap, the current market cap for Injective (INJ) stands at $1.29 billion, with a price of $12.91. Despite a recent decline in trading volume and price, INJ gained 21.03% over the past two months, reflecting interest amidst evolving market conditions.
Steven McClurg, Founder, Canary Capital, noted, “The ETF will allow investors to benefit from both price appreciation and staking yields — without the technical risks of direct on-chain participation.”
| | | --- | | DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |